4-(Bromoacetyl)pyridine hydrobromide, 98%
4-(Bromoacetyl)pyridine hydrobromide, 98%
4-(Bromoacetyl)pyridine hydrobromide, 98%
4-(Bromoacetyl)pyridine hydrobromide, 98%
Thermo Scientific Chemicals

4-(Bromoacetyl)pyridine hydrobromide, 98%

CAS: 5349-17-7 | C7H7Br2NO | 280.947 g/mol
Have Questions?
Change viewbuttonViewtableView
Quantity:
1 g
5 g
25 g
Catalog number H32285.03
also known as H32285-03
Price (USD)
72.65
Special offer
Online exclusive
Ends: 30-Jun-2026
85.50
Save 12.85 (15%)
Each
Add to cart
Quantity:
1 g
Request bulk or custom format
Price (USD)
72.65
Special offer
Online exclusive
Ends: 30-Jun-2026
85.50
Save 12.85 (15%)
Each
Add to cart
Chemical Identifiers
CAS5349-17-7
IUPAC Namehydrogen 2-bromo-1-(pyridin-4-yl)ethan-1-one bromide
Molecular FormulaC7H7Br2NO
InChI KeyRGALBQILADNMKA-UHFFFAOYSA-N
SMILES[H+].[Br-].BrCC(=O)C1=CC=NC=C1
View more
SpecificationsSpecification SheetSpecification Sheet
FormPowder
Assay (Titration ex Bromide)≥97.5 to ≤102.5%
Appearance (Color)White to cream to pale yellow
Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase 4-(Bromoacetyl)pyridine hydrobromide was used to prepare 2-Phenyl-4-(4-pyridyl)imidazole.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase 4-(Bromoacetyl)pyridine hydrobromide was used to prepare 2-Phenyl-4-(4-pyridyl)imidazole.

Solubility
Soluble in water.

Notes
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Store away from strong oxidizing agents, bases.
RUO – Research Use Only
Nigel J. Liverton,; John W. Butcher,; Christopher F. Claiborne,; David A. Claremon,; Brian E. Libby,; Kevin T. Nguyen,; Steven M. Pitzenberger,; Harold G. Selnick,; Garry R. Smith,; Andrew Tebben. Design and Synthesis of Potent, Selective, and Orally Bioavailable Tetrasubstituted Imidazole Inhibitors of p38 Mitogen-Activated Protein Kinase . J. Med. Chem. 1999, 42 (12),2180-2190.